GO-BIO Award 2014
PoreGenic won the highly respected GO-Bio Phase II prize of the German Federal Ministry of Research and Education (BMBF) and a grant of + € 2 million! Please click here.
Fig.: The GO-Bio laureates 2014. Seven Phase-I projects and two Phase-II projects were awarded grants. (photo: BIO Deutschland e.V.)
Online survey 2014
We would highly appreciate your input into our product development efforts. Please answer six short questions regarding the academic and the pharmaceutical version of the product in the following survey links. This takes just five minutes.
Your statements are very valuable to us, both in terms of the product development process and with regard to sharing first-hand market feedback with our investors. We would be very grateful if you could answer the questions as soon as possible.
Proof of Concept: Recently, our prototype has provided proof of concept with its gigaseal patch clamp analysis of mammalian neuronal networks!
Rationale: PoreGenic's goal is to address a crucial bottle-neck in research, drug discovery and pre-clinical drug development with an Automated Patch Clamp (APC) system for cellular networks. Currently, there are no APC test systems with high throughput capability available that can generate such in vivo-like data.
Applications: PoreGenic identified +15 biopharmaceutical applications that are feasible only with our system: For example, PoreGenic's know-how will allow pharmaceutical companies, CROs and the academic community to screen CNS compounds for their effect on neuronal long-term potentiation, the most fundamental process of neuronal plasticity and learning. This will help fight Alzheimer's, Parkinson's and other neurodegenerative diseases.
Project: The PoreGenic team started to develop its technology in 2009. In 2010, PoreGenic was awarded with the highly respected GO-Bio prize (+ € 3 million) of the BMBF for its chip-based APC approach.
Company: PoreGenic Biosciences GmbH will spin-off from Rostock University in 2014.